Free shipping on all orders over $ 500

TSR-011

Cat. No. M2201

All AbMole products are for research use only, cannot be used for human consumption.

TSR-011 Structure
Synonym:

Belizatinib

Size Price Availability Quantity
5mg USD 105 In stock
10mg USD 170 In stock
25mg USD 340 In stock
50mg USD 480 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

TSR-011 is an orally available ALK inhibitor being developed for the treatment of solid tumors including NSCLC. ALK is known to be involved in certain types of cancers, including subsets of non-small cell lung cancer, neuroblastoma and lymphoma. TSR-011 is a potent inhibitor of both anaplastic lymphoma kinase (ALK) and tropomyosin-related kinases (TRK). Preliminary results after eight weeks of treatment with TSR-011 demonstrated disease control (partial responses plus stable disease) in 11 of 17 (65%) evaluable patients treated with TSR-011.

Chemical Information
Molecular Weight 577.73
Formula C33H44FN5O3
CAS Number 1357920-84-3
Solubility (25°C) 100 mg/mL in DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Yekaterina B Khotskaya, et al. Targeting TRK family proteins in cancer

[2] Wade T Iams, et al. Anaplastic Lymphoma Kinase as a Therapeutic Target in Non-Small Cell Lung Cancer

[3] Georg Pall. The next-generation ALK inhibitors

[4] Mark M Awad, et al. ALK inhibitors in non-small cell lung cancer: crizotinib and beyond

Related ALK Products
AP26113 (Brigatinib)

AP26113 (Brigatinib) is a highly potent ALK inhibitor with IC50 of 0.6 nM.

X-376

X-376 is a potent and highly specific ALK small molecule tyrosine kinase inhibitor with IC50 of 0.61 nM.

SB431542

SB-431542 is a potent and selective inhibitor of the transforming growth factor-β (TGF-β) type I receptor activin receptor-like kinase ALK5 (IC50 = 94 nM).

RepSox

RepSox (ALK5 Inhibitor II) is a potent and ATP-competitive inhibitor of the TGF-β type I receptor ALK5 (IC50 values are 0.004 and 0.023 μM for ALK5 autophosphorylation and ALK5 binding respectively).

LDN-193189

LDN-193189 is a highly potent small molecule inhibitor of bone morphogenetic protein (BMP) type I receptors ALK2 and ALK3.

  Catalog
Abmole Inhibitor Catalog




Keywords: TSR-011, Belizatinib supplier, ALK, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2026 AbMole BioScience. All Rights Reserved.